Hematology
Blood & lymphatic clinical trials
Anemia, clotting disorders, and other conditions of the blood and lymphatic system. We’re tracking 5,088 recruiting studies in this area right now.
By phase
- Not applicable2,108
- Phase 21,119
- Phase 1824
- Phase 1/Phase 2483
- Phase 3350
- Phase 4126
- Phase 2/Phase 378
Top conditions
- Multiple Myeloma334
- Acute Myeloid Leukemia291
- Lymphoma183
- Sickle Cell Disease142
- Myelodysplastic Syndromes129
- Acute Lymphoblastic Leukemia123
- Chronic Lymphocytic Leukemia100
- Leukemia100
- Follicular Lymphoma74
- Hematologic Malignancy68
- Myelodysplastic Syndrome68
- Hodgkin Lymphoma67
- Anemia62
- Mantle Cell Lymphoma62
- Diffuse Large B Cell Lymphoma57
- Lymphedema49
- Non-Hodgkin Lymphoma49
- Small Lymphocytic Lymphoma49
Leading sponsors
- Institute of Hematology & Blood Diseases Hospital, China148
- M.D. Anderson Cancer Center147
- National Cancer Institute (NCI)96
- The First Affiliated Hospital of Soochow University68
- Memorial Sloan Kettering Cancer Center65
- Mayo Clinic61
- City of Hope Medical Center59
- Assistance Publique - Hôpitaux de Paris46
- St. Jude Children's Research Hospital43
- Peking University People's Hospital41
Where studies are running
- California406
- Texas186
- Maryland149
- Alabama147
- Arizona123
- Florida110
- Massachusetts101
- New York98
- Ohio71
- Minnesota68
Recruiting studies5,088 total
- NCT06664775RecruitingPhase 3
Comparing two bleeding-control patches during open surgery
This study tests a special patch called TachoSil against a standard surgical pad (Surgicel) to see which works better for controlling minor oozing during open abdominal, chest, or pelvic surgeries. It may be an option if you are having certain types of surgery and have a small area of mild bleeding that needs help to stop.
Torrance, CaliforniaAges 1 month+ - NCT06629311Recruiting
Blood recycling device study in heart surgery
This trial looks at how a device that collects and reuses your own blood during heart surgery works. It may help reduce the need for donated blood.
Strasbourg, Bas-RhinAges 18 years+ - NCT06611839RecruitingPhase 1/Phase 2
Combination therapy for IDH1-mutated AML
This trial tests a combination of three drugs (venetoclax, ivosidenib, and azacitidine) for people newly diagnosed with a specific type of AML that has an IDH1 mutation. The goal is to see if this mix works better than standard treatments.
Tianjin, Tianjin MunicipalityAges 14 years+ - NCT06657391RecruitingPhase 2
Study of a new drug to prevent graft-versus-host disease in thalassemia patients
This trial tests a drug called an anti-CD25 antibody to see if it can prevent graft-versus-host disease (a condition where donor cells attack the body) in people with transfusion-dependent thalassemia who are getting a stem cell transplant from a partially matched or unrelated donor.
Maoming, GuangdongAges 3–20 - NCT06647017Recruiting
Nerve stimulation to reduce blood loss during dialysis graft placement
This trial tests whether a gentle nerve stimulation device placed behind the ear can lower blood loss during surgery to place a dialysis graft (a tube for dialysis treatment). It may help make the procedure safer.
Watkinsville, GeorgiaAges 18–75 - NCT06672705RecruitingPhase 1
Epcoritamab for post-transplant lymphoma that didn't respond to treatment
This trial tests a new drug called epcoritamab for people whose PTLD (a type of lymphoma that can happen after an organ transplant) has come back or hasn't been helped by standard treatments. The goal is to see if epcoritamab can shrink or control the cancer.
St Louis, MissouriAges 18 years+ - NCT06639854Recruiting
CMV immunity test to guide antiviral prevention after transplant
This trial uses a blood test to measure your immune system's ability to fight CMV, a common virus after transplant. The results will help your doctors decide if you can safely stop taking the antiviral medication letermovir earlier to avoid unnecessary side effects.
Houston, TexasAges 18 years+ - NCT06684964Recruiting
Real-world study of asciminib for chronic CML in Saudi Arabia
This study is watching how well asciminib (Scemblix) works in real life for people with chronic-phase CML in Saudi Arabia. If you've already tried two or more targeted therapies (TKIs) and recently started asciminib, this study may help doctors understand more about its effectiveness and side effects.
DammamAges 18–99 - NCT06563245RecruitingPhase 2/Phase 3
Brentuximab vedotin for Hodgkin lymphoma in children and young adults
This trial tests the drug brentuximab vedotin for children and young adults (ages 2 to under 35) who have just been diagnosed with classical Hodgkin lymphoma. The treatment is guided by PET/CT scans to see how well it works.
ShanghaiAges 2–35 - NCT06575309Recruiting
Blood clotting in pregnancy and the effect of blood thinner
This study looks at how blood clotting changes during pregnancy and how a common blood thinner affects clotting in the lab. It may help doctors understand pregnancy-related clotting risks better.
Clermont-FerrandAges 18–55 - NCT06581900Recruiting
Vitamin B12 in kids with sickle cell disease
This study looks at how children with sickle cell disease process vitamin B12 when exposed to a gas painkiller called MEOPA. It may help doctors understand how to manage treatment better.
ReimsAges 2–18 - NCT06568913Recruiting
TPO-RA medicines for children with long-term ITP
This study looks at how well certain medicines (called thrombopoietin receptor agonists, or TPO-RAs) work for children with long-term ITP that did not improve with steroids. The goal is to see if these medicines can help raise platelet counts and reduce bleeding.
SohagAges 1–18 - NCT06562777Recruiting
How symptoms differ between men and women during immunotherapy
This study looks at how symptoms during immunotherapy (a cancer treatment that boosts your immune system) may differ between men and women. Researchers will follow people with cancer who are starting immunotherapy to see if men and women report different side effects.
Portland, OregonAges 18 years+ - NCT06512545Recruiting
Modified second stem cell transplant for graft failure
This study tests a modified second stem cell transplant for people whose first transplant failed. It uses half-matched (haploidentical) donor cells to try to restore healthy blood cells and treat the cancer.
Beijing, Beijing MunicipalityAges 14 years+ - NCT06552559RecruitingPhase 1/Phase 2
Selinexor plus ICE chemo for brain-involved B-cell lymphoma
This trial tests a new drug, selinexor, combined with standard ICE chemotherapy for patients whose B-cell non-Hodgkin lymphoma has spread to the brain or spinal cord. It aims to see if adding selinexor improves treatment results.
SeoulAges 18 years+ - NCT06558253RecruitingPhase 1
Coenzyme I for blood recovery after cord blood transplant
This trial tests whether a drug called Coenzyme I (given by injection) can help your blood cells recover faster after a cord blood transplant for blood cancer. It is for people who are getting this type of transplant for the first time and are in fairly good health otherwise.
Hefei, AnhuiAges 18–60 - NCT06420167RecruitingPhase 2
Dapagliflozin for kidney AL amyloidosis
This trial tests whether a diabetes medicine called dapagliflozin can help protect kidney function in people with AL amyloidosis. You must live in Michigan and have stable or improving protein in your urine.
Detroit, MichiganAges 18 years+ - NCT06343792RecruitingPhase 2
Testing RLS-0071 for steroid-resistant acute graft-versus-host disease
This trial tests a new drug, RLS-0071, for people who are hospitalized with acute graft-versus-host disease that hasn't improved with steroids. It aims to see if the drug is safe and can help control the condition.
Duarte, CaliforniaAges 12 years+ - NCT06393361RecruitingPhase 2
Combination therapy for relapsed Hodgkin lymphoma without transplant
This trial tests a combination of two oral targeted drugs (chidamide and decitabine) plus an immunotherapy drug (anti-PD-1 antibody) for people with classical Hodgkin lymphoma that has not responded to at least two prior treatments and who cannot or choose not to have a stem cell transplant. The goal is to see if this three-drug combination can shrink tumors and help control the disease.
BeijingAges 18–75 - NCT06429787Recruiting
Safety study of BALFAXAR vs. Kcentra for urgent blood thinner reversal
This study compares the safety of two medications, BALFAXAR and Kcentra, used to quickly reverse the effects of blood thinners (like warfarin) in people who need urgent surgery or a procedure. It helps doctors understand which option may be safer for patients in this situation.
Boston, MassachusettsAges 18 years+ - NCT06355258RecruitingPhase 1
Troxerutin to prevent blood clots in COVID-19 patients
This trial tests if the drug troxerutin can prevent dangerous blood clots in adults hospitalized with mild or severe COVID-19. If you have COVID-19 and are not already on blood thinners or at high risk for bleeding, you may be able to join.
Shaoxing, ZhejiangAges 18 years+ - NCT06470971RecruitingPhase 2
Siltuximab to prevent severe side effects during immunotherapy rechallenge
This trial tests if siltuximab can prevent severe immune-related side effects when patients restart immunotherapy (anti-PD-1/PD-L1) after previous severe side effects. It aims to make rechallenge safer for people with advanced cancer.
Columbus, OhioAges 18 years+ - NCT06466395RecruitingPhase 1
Hyper-CVAD plus venetoclax for relapsed pediatric leukemia
This trial tests a combination of chemotherapy drugs (hyper-CVAD) plus a targeted pill called venetoclax for children and young adults with a type of leukemia that has returned or not responded to treatment. The goal is to see if this combo can help control the leukemia.
Houston, TexasAges 2–21 - NCT06425614Recruiting
Blood Cell Recycling During Heart Surgery Trial
This trial tests whether giving back a patient's own platelets and red blood cells during heart surgery can reduce bleeding and the need for donor blood transfusions. It is for people having certain types of high-risk heart surgery with a heart-lung machine.
Bordeaux, FranceAges 18 years+
Common questions
- How many blood & lymphatic clinical trials are recruiting?
- Clin2 is tracking 5,088 recruiting hematology studies from the U.S. registry right now, out of 7,677 we cover in this area in total.
- What does “Blood & lymphatic” cover here?
- Anemia, clotting disorders, and other conditions of the blood and lymphatic system. We group each study into blood & lymphatic based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a blood & lymphatic trial near me?
- Use the search to filter blood & lymphatic studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
- Cancer
- Brain & nervous system
- Heart & circulation
- Hormones & metabolism
- Mental health
- Digestive system
- Lungs & breathing
- Immune system & allergy
- Women’s health & pregnancy
- Skin
- Kidney & urinary
- Infections
- Genetic & congenital
- Bones, joints & muscles
- Pain
- Injuries & trauma
- Mouth & dental
- Eyes & vision
- Ear, nose & throat
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.